Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Andreani

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer Research|March 24, 2017
The Role of PIAS SUMO E3-Ligases in CancerAndrea Rabellino, Cristina Andreani, Pier Paolo Scaglioni
Current Issues in Molecular Biology|August 20, 2019
Roles of Ubiquitination and SUMOylation in the Regulation of AngiogenesisAndrea Rabellino, Cristina Andreani, Pier Paolo Scaglioni
Frontiers in Oncology|August 1, 2022
Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?Cristina Andreani, Caterina Bartolacci, Pier Paolo Scaglioni
Current Protein & Peptide Science|January 13, 2017
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast CancerCaterina Bartolacci, Cristina Andreani, Augusto Amici, et al.
Frontiers in Molecular Biosciences|September 6, 2021
Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and TherapyCaterina Bartolacci, Cristina Andreani, Yasmin El-Gammal, et al.
Cellular Signalling|November 28, 2013
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signalingChiara Garulli, Cristina Kalogris, Lucia Pietrella, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell LinesRossana Galassi, Nicola Sargentoni, Sofia Renzi, et al.
Aging|February 28, 2017
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitorCristina Andreani, Caterina Bartolacci, Kathleen Wijnant, et al.
Cancer Immunology Research|October 18, 2018
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast CancerCaterina Bartolacci, Cristina Andreani, Claudia Curcio, et al.
Nature Cancer|December 17, 2024
The 2024 generationShruthy Suresh Aggarwal, Cristina Andreani, Zihou Deng, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|March 24, 2017
The Role of PIAS SUMO E3-Ligases in CancerAndrea Rabellino, Cristina Andreani, Pier Paolo Scaglioni
Current Issues in Molecular Biology|August 20, 2019
Roles of Ubiquitination and SUMOylation in the Regulation of AngiogenesisAndrea Rabellino, Cristina Andreani, Pier Paolo Scaglioni
Frontiers in Oncology|August 1, 2022
Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?Cristina Andreani, Caterina Bartolacci, Pier Paolo Scaglioni
Current Protein & Peptide Science|January 13, 2017
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast CancerCaterina Bartolacci, Cristina Andreani, Augusto Amici, et al.
Frontiers in Molecular Biosciences|September 6, 2021
Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and TherapyCaterina Bartolacci, Cristina Andreani, Yasmin El-Gammal, et al.
Cellular Signalling|November 28, 2013
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signalingChiara Garulli, Cristina Kalogris, Lucia Pietrella, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell LinesRossana Galassi, Nicola Sargentoni, Sofia Renzi, et al.
Aging|February 28, 2017
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitorCristina Andreani, Caterina Bartolacci, Kathleen Wijnant, et al.
Cancer Immunology Research|October 18, 2018
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast CancerCaterina Bartolacci, Cristina Andreani, Claudia Curcio, et al.
Nature Cancer|December 17, 2024
The 2024 generationShruthy Suresh Aggarwal, Cristina Andreani, Zihou Deng, et al.
Pageof 3